
Despite the well-documented efficacy and different zzso and zzso properties of different forms of nicotine replacement therapy, empirical data are insufficient to guide practitioners in selecting a particular form of treatment for individual patients with tobacco zzso 

To evaluate the comparative efficacy of zzso nicotine and nicotine zzso spray and identify zzso of treatment zzso 

zzso zzso clinical trial with a zzso follow-up zzso 

2 zzso smoking zzso research zzso 

299 zzso smokers who were followed for 6 months after the target quit zzso 

zzso group counseling and 8 weeks of therapy with nicotine zzso spray or zzso zzso 

zzso zzso smoking history, depression symptoms, and body mass index were measured at zzso Smoking practices were zzso verified at the end of treatment and at 6 months after the target quit zzso 

zzso rates for the zzso nicotine and nicotine zzso spray groups were not significantly different at zzso follow-up zzso zzso zzso zzso zzso zzso zzso in zzso rates for zzso of smokers were statistically significant zzso zzso Smokers who had low to moderate dependence levels, were not obese, and were white achieved higher zzso rates with zzso zzso whereas smokers who were highly dependent, obese, or members of minority groups achieved higher zzso rates with zzso zzso 

The zzso findings need confirmation in additional large studies before they are routinely zzso 

zzso weight, and level of nicotine dependence may help identify smokers who have greater or lesser zzso rates with either zzso or zzso spray zzso 

